Alliance Wealth Advisors LLC UT Purchases 63 Shares of STERIS plc (NYSE:STE)

Alliance Wealth Advisors LLC UT raised its position in shares of STERIS plc (NYSE:STE) by 1.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,878 shares of the medical equipment provider’s stock after purchasing an additional 63 shares during the period. Alliance Wealth Advisors LLC UT’s holdings in STERIS were worth $852,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of STE. Impax Asset Management Group plc grew its holdings in STERIS by 419.1% during the fourth quarter. Impax Asset Management Group plc now owns 964,935 shares of the medical equipment provider’s stock valued at $211,430,000 after purchasing an additional 779,038 shares during the period. Envestnet Asset Management Inc. grew its holdings in STERIS by 58.4% during the third quarter. Envestnet Asset Management Inc. now owns 586,380 shares of the medical equipment provider’s stock valued at $128,663,000 after purchasing an additional 216,113 shares during the period. Artemis Investment Management LLP bought a new position in STERIS during the fourth quarter valued at $32,687,000. Jennison Associates LLC grew its holdings in STERIS by 60.2% during the fourth quarter. Jennison Associates LLC now owns 268,029 shares of the medical equipment provider’s stock valued at $58,926,000 after purchasing an additional 100,734 shares during the period. Finally, Lord Abbett & CO. LLC grew its holdings in STERIS by 65.5% during the third quarter. Lord Abbett & CO. LLC now owns 244,659 shares of the medical equipment provider’s stock valued at $53,683,000 after purchasing an additional 96,800 shares during the period. 94.69% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. TheStreet raised STERIS from a “c+” rating to a “b” rating in a report on Wednesday, February 7th. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a report on Friday, April 12th. KeyCorp assumed coverage on STERIS in a report on Tuesday, February 6th. They issued an “overweight” rating and a $253.00 price target for the company. JMP Securities reaffirmed a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a report on Thursday, February 8th. Finally, Stephens reaffirmed an “overweight” rating and issued a $250.00 price target on shares of STERIS in a report on Friday, February 9th. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $239.60.

STERIS Price Performance

NYSE:STE traded up $2.36 during trading hours on Friday, hitting $203.90. 318,142 shares of the company’s stock traded hands, compared to its average volume of 558,812. The firm has a market cap of $20.15 billion, a P/E ratio of 35.71 and a beta of 0.79. STERIS plc has a 52 week low of $181.78 and a 52 week high of $254.00. The business’s fifty day simple moving average is $221.18 and its two-hundred day simple moving average is $216.80. The company has a quick ratio of 1.49, a current ratio of 2.43 and a debt-to-equity ratio of 0.50.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share for the quarter, beating analysts’ consensus estimates of $2.17 by $0.05. STERIS had a return on equity of 13.67% and a net margin of 10.48%. The business had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.35 billion. During the same quarter last year, the business posted $2.02 earnings per share. The company’s revenue for the quarter was up 14.8% on a year-over-year basis. On average, research analysts anticipate that STERIS plc will post 8.67 earnings per share for the current fiscal year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 22nd. Stockholders of record on Friday, February 23rd were issued a $0.52 dividend. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a $2.08 annualized dividend and a dividend yield of 1.02%. STERIS’s dividend payout ratio is currently 36.43%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.